Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed have?

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has 189 citations in the OpenAlex counts ScholarIQ stores.

When was Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed published?

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has 2016 year in the ScholarIQ index.

What is the open-access status of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has closed oa status in the ScholarIQ index.

What is the DOI of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

The DOI for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.

What is the PMID of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

The PMID for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.

What is the OpenAlex record for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

The OpenAlex for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.